Protalix BioTherapeutics, Inc. (PLX)
Healthcare • Biotechnology
StockNYSE AmericanUnited StatesUS74365A3095
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Protalix BioTherapeutics, Inc., and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 13 Nov 2026 12:33. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 12 Aug 2026 06:00 | -0.01 | 0.05 | +600.0% | Beat |
| 13 May 2026 06:00 | -0.01 | 0.22 | +2,300.0% | Beat |
| 18 Mar 2026 06:00 | 0.01 | -0.07 | -1,500.0% | Miss |
| 13 Nov 2025 06:00 | 0.06 | 0.03 | -45.5% | Miss |
| 14 Aug 2025 06:00 | 0.03 | — | -100.0% | — |
| 09 May 2025 06:00 | 0.08 | -0.05 | -162.5% | Miss |
| 17 Mar 2025 06:00 | 0.07 | 0.09 | +28.6% | Beat |
| 14 Nov 2024 06:00 | 0.06 | 0.03 | -50.0% | Miss |
| 14 Aug 2024 06:00 | 0.02 | -0.03 | -250.0% | Miss |
| 10 May 2024 06:00 | -0.02 | -0.06 | -200.0% | Miss |
| 14 Mar 2024 06:00 | -0.02 | -0.07 | -180.0% | Miss |
| 06 Nov 2023 06:00 | -0.07 | -0.03 | +57.1% | Beat |
| 07 Aug 2023 06:00 | -0.04 | 0.21 | +625.0% | Beat |
| 27 Feb 2023 06:00 | -0.15 | -0.07 | +53.3% | Beat |
| 14 Nov 2022 06:00 | -0.15 | -0.07 | +53.3% | Beat |
| 15 Aug 2022 06:00 | -0.18 | -0.11 | +38.9% | Beat |
| 16 May 2022 06:00 | -0.04 | -0.05 | -25.0% | Miss |
| 31 Mar 2022 07:00 | -0.11 | -0.14 | -27.3% | Miss |
| 15 Nov 2021 06:00 | -0.12 | -0.09 | +25.0% | Beat |
| 16 Aug 2021 06:00 | -0.10 | -0.25 | -150.0% | Miss |
| 14 May 2021 06:00 | -0.17 | -0.14 | +17.7% | Beat |
| 30 Mar 2021 06:00 | -0.04 | 0.03 | +175.0% | Beat |
| 29 Oct 2020 06:00 | -0.08 | -0.14 | -75.0% | Miss |
| 10 Aug 2020 06:00 | -0.20 | -0.13 | +36.6% | Beat |
| 01 Jun 2020 06:00 | -0.30 | 0.10 | +133.3% | Beat |
| 12 Mar 2020 16:00 | -0.63 | 0.01 | +101.6% | Beat |
| 07 Nov 2019 06:00 | -0.35 | -0.20 | +42.9% | Beat |
| 08 Aug 2019 06:00 | -0.30 | -0.50 | -66.7% | Miss |
| 06 May 2019 07:00 | -0.25 | -0.50 | -100.0% | Miss |
| 18 Mar 2019 06:00 | -0.45 | 0.70 | +255.6% | Beat |
| 07 Nov 2018 07:00 | -0.40 | -1.00 | -150.0% | Miss |
| 09 Aug 2018 07:00 | -0.40 | -0.80 | -100.0% | Miss |
| 09 May 2018 07:00 | -0.90 | -0.60 | +33.3% | Beat |
| 06 Mar 2018 07:00 | -0.60 | -1.10 | -83.3% | Miss |
| 08 Nov 2017 07:00 | -0.45 | -0.90 | -100.0% | Miss |
| 09 Aug 2017 07:00 | -0.35 | -1.08 | -209.4% | Miss |
| 10 May 2017 07:00 | -0.90 | -0.70 | +22.2% | Beat |
| 16 Mar 2017 08:00 | -1.10 | -1.27 | -15.6% | Miss |
| 09 Nov 2016 08:00 | -1.00 | -0.70 | +30.0% | Beat |
| 08 Aug 2016 16:00 | -0.90 | -1.10 | -22.2% | Miss |
| 09 May 2016 07:00 | -0.75 | -0.90 | -20.0% | Miss |
| 09 Nov 2015 16:00 | -0.80 | -0.40 | +50.0% | Beat |
| 10 Aug 2015 16:00 | -0.80 | -0.50 | +37.5% | Beat |
| 07 May 2015 16:00 | -0.80 | -0.60 | +25.0% | Beat |
| 12 Mar 2015 16:00 | -0.60 | -0.90 | -50.0% | Miss |
| 10 Nov 2014 18:00 | -0.80 | -0.90 | -12.5% | Miss |
| 07 Aug 2014 16:00 | -0.67 | -0.70 | -5.0% | Miss |
| 08 May 2014 16:00 | -0.67 | -0.80 | -20.0% | Miss |
| 13 Mar 2014 16:00 | -0.24 | -1.20 | -400.0% | Miss |
| 07 Nov 2013 16:00 | -0.40 | -0.60 | -50.0% | Miss |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2025 | 52.7M | -1.2% | -6.6M | -12.5% | -0.08 | -300.0% | -13.6M |
| 2024 | 53.4M | -18.5% | 2.9M | 5.5% | 0.04 | -55.6% | 7.4M |
| 2023 | 65.5M | +37.5% | 8.3M | 12.7% | 0.09 | +129.0% | -2.5M |
| 2022 | 47.6M | — | -14.9M | -31.3% | -0.31 | — | -25.6M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| Nov 2026 In progress | 2.60 | 3.14 | 2.45 | 2.96 | +14.29% | 12,522,900 | |
| Oct 2026 | 2.77 | 2.80 | 2.46 | 2.59 | -6.16% | 17,967,300 | |
| Sep 2026 | 2.61 | 2.85 | 2.57 | 2.76 | +7.39% | 15,332,400 | |
| Aug 2026 | 2.36 | 2.71 | 2.17 | 2.57 | +8.44% | 16,967,300 | |
| Jul 2026 | 2.31 | 2.48 | 2.20 | 2.37 | +1.72% | 11,896,200 | |
| Jun 2026 | 2.10 | 2.38 | 1.95 | 2.33 | +10.43% | 14,594,200 | |
| May 2026 | 2.16 | 2.19 | 1.88 | 2.11 | -1.86% | 19,002,700 | |
| Apr 2026 | 2.21 | 2.39 | 2.07 | 2.15 | -0.92% | 12,814,700 | |
| Mar 2026 | 2.82 | 3.05 | 2.03 | 2.17 | -24.65% | 24,178,500 | |
| Feb 2026 | 2.35 | 3.19 | 2.35 | 2.88 | +23.08% | 35,487,700 | |
| 51 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- PLX: Elfabrio Estimates Up, Again (opens in a new tab) 11 Nov 2026 16:01
- Protalix BioTherapeutics, Inc. Q3 2026 Earnings Call Summary (opens in a new tab) Moby · 11 Nov 2026 03:02
- Protalix BioTherapeutics, Inc. (PLX) Q3 2026 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 10 Nov 2026 15:01
- Protalix: Q3 Earnings Snapshot (opens in a new tab) Associated Press · 10 Nov 2026 11:56
- Protalix BioTherapeutics Reports Third Quarter 2026 Financial and Business Results (opens in a new tab) 10 Nov 2026 11:45
- Protalix BioTherapeutics Q3 2026 Earnings Call Transcript (opens in a new tab) Benzinga · 10 Nov 2026 09:47
- Protalix BioTherapeutics Affirms FY2026 Sales Guidance of $78.000M-$83.000M vs $71.359M Est (opens in a new tab) Benzinga · 10 Nov 2026 07:48
- Protalix Biotherapeutics To Present Individual Participant Results From PK And PD Analysis Of Higher-Dose Cohorts Of Its Phase 1 Single Ascending Dose Study Of PRX-115, At ACR Convergence 2026 (opens in a new tab) Benzinga · 09 Nov 2026 07:47
- Protalix BioTherapeutics to Announce Third Quarter 2026 Financial Results and Business Update on November 10, 2026 (opens in a new tab) 03 Nov 2026 11:50
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 3.13 USD
- Market cap
- 249.6M
- Exchange
- NYSE American
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow PLX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.